Sensus Healthcare Champions Skin Cancer Awareness Month with Focus on Education, Prevention, and Non-Invasive Treatment Innovations
May marks Skin Cancer Awareness Month, and Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company pioneering non-invasive and minimally invasive treatments for oncological and non-oncological skin conditions, is leading the charge to educate the public, empower healthcare professionals, and promote advanced, patient-centric treatment options for skin cancer. Through a series of robust outreach initiatives, the company aims to elevate understanding of skin cancer prevention, early detection, and the benefits of innovative, non-surgical therapies.
Raising Awareness: A Multi-Channel Strategy
Throughout the month of May, Sensus Healthcare is engaging in a comprehensive campaign to increase awareness of skin cancer, the most commonly diagnosed cancer globally. In the United States alone, more than 5 million cases of skin cancer are treated annually, underscoring the urgency of educational and preventive efforts.
Sensus is leveraging its communication platforms—including educational newsletters, interactive social media campaigns, and strategic partnerships with dermatologists and healthcare organizations—to inform the public about risk factors, warning signs, and safe treatment alternatives.
“Our commitment during Skin Cancer Awareness Month—and every month—is to improve access to treatment while educating individuals about the importance of early detection and prevention,” said Joe Sardano, Chief Executive Officer of Sensus Healthcare. “With skin cancer cases continuing to rise, awareness coupled with access to patient-friendly, non-invasive technologies is more critical than ever.”
Patient-Centered Technologies: IG-SRT and SRT-100 Vision
Central to Sensus Healthcare’s mission is its groundbreaking portfolio of non-invasive treatment systems. Two flagship technologies, Image-Guided Superficial Radiation Therapy (IG-SRT) and the SRT-100 Vision, are designed to treat non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma—without surgery, scarring, or extensive recovery periods.
The IG-SRT system offers targeted, image-guided radiation therapy that preserves healthy surrounding tissue while delivering precise doses of therapeutic radiation directly to cancerous cells. This high level of accuracy enhances patient comfort and reduces side effects compared to more invasive procedures.
The SRT-100 Vision system integrates high-frequency ultrasound imaging, allowing clinicians to visualize the lesion and surrounding tissue in real time. This enhances treatment precision, minimizes unnecessary radiation exposure, and allows for personalized treatment protocols tailored to each patient’s unique condition.
Together, these systems represent a paradigm shift in how early-stage skin cancers are treated—particularly for patients who are elderly, have comorbidities, or are seeking alternatives to surgical excision or Mohs surgery.
Removing Barriers: The Fair Deal Agreement
To further expand access to its cutting-edge technology, Sensus Healthcare launched the Fair Deal Agreement—a shared-revenue acquisition program designed to eliminate financial obstacles for dermatology practices.
Launched just a year ago, the program has already seen strong adoption among clinics nationwide. By requiring no upfront capital investment, the Fair Deal Agreement makes it easier for practices to offer state-of-the-art treatment without the burden of traditional equipment purchasing costs. This model supports broader access to non-invasive care while improving outcomes and satisfaction for patients who may otherwise be underserved.
“With the Fair Deal Agreement, we’ve enabled more providers to integrate our technologies into their practice, which directly translates to increased patient access to life-changing care,” added Sardano. “It’s a win-win for providers and patients alike.”
Joining the Movement: Collaborative Awareness Initiatives
Sensus Healthcare is inviting investors, healthcare professionals, community leaders, and the general public to join its campaign throughout May by participating in awareness initiatives, sharing educational resources, and helping to spread the word about skin cancer prevention and treatment.
The company encourages all stakeholders to take an active role in encouraging regular skin checks, sunscreen usage, and sun-safe behaviors, especially as summer approaches and sun exposure increases.
“By working together—industry leaders, clinicians, patients, and families—we can create a ripple effect of awareness that ultimately saves lives,” said Sardano. “Skin cancer is largely preventable and highly treatable when caught early. Education is our first and most powerful line of defense.”
Understanding the Risk: Prevention Tips from Sensus Healthcare
While genetics and family history can contribute to the development of skin cancer, ultraviolet (UV) radiation from the sun and tanning beds remains the most significant environmental risk factor. Sensus Healthcare is committed to not only treating skin cancer but helping individuals avoid it altogether. The company offers the following guidelines for reducing personal risk:
1. Limit Sun Exposure
Avoid direct sunlight during peak UV radiation hours—typically between 10 a.m. and 4 p.m.—especially in summer months. Seek shade whenever possible, particularly during outdoor activities.
2. Wear Sunscreen Daily
Use a broad-spectrum sunscreen with an SPF of 30 or higher every day, even on cloudy days. Reapply every two hours, and immediately after swimming or sweating.
3. Wear Protective Clothing
Opt for long-sleeved shirts, wide-brimmed hats, and UV-protective sunglasses. Specialized sun-protective clothing is also available and offers enhanced protection without compromising comfort.
4. Avoid Tanning Beds
Artificial tanning beds emit concentrated UV radiation and significantly increase the risk of melanoma and other skin cancers. Consider sunless tanning products as a safer alternative.
5. Perform Regular Skin Checks
Examine your skin monthly for unusual moles, new growths, or changes in existing spots. Use the “ABCDE” rule—Asymmetry, Border, Color, Diameter, and Evolving characteristics—to evaluate suspicious lesions. Schedule annual full-body skin exams with a board-certified dermatologist, even if you don’t notice visible changes.
Driving Toward a Safer Future
As skin cancer continues to impact millions of lives each year, Sensus Healthcare’s comprehensive approach—combining prevention, education, and innovative non-invasive technology—is helping shape the future of skin cancer care. The company’s ongoing initiatives during Skin Cancer Awareness Month are part of a broader vision to make effective, accessible treatment available to all while driving down unnecessary surgical procedures and post-operative complications.
Whether you’re a provider considering new treatment options, a patient seeking alternatives to surgery, or simply someone who wants to be more informed, Sensus Healthcare encourages you to take action this May.
To learn more about Sensus Healthcare’s skin cancer technologies, its Skin Cancer Awareness Month initiatives, or to access resources for patients and providers, please visit www.sensushealthcare.com.
